Biotech

All Articles

AvenCell bags $112M to snap 'switchable' CAR-Ts in the clinic

.AvenCell Rehabs has safeguarded $112 million in collection B funds as the Novo Holdings-backed biot...

China- located biotech programs ph. 3 after finding midstage eye data

.China-based Minghui Drug has actually connected its own thyroid eye condition therapy to a reductio...

Sangamo slashes opportunity to market for Fabry gene therapy as FDA consents to increased approval bundle

.Sangamo Rehabs has identified a shortcut to market for its own Fabry illness candidate, straighteni...

Otsuka's renal ailment medication enhances UPCR degrees in ph. 3 trial

.Otsuka Drug's kidney disease medication has actually struck the key endpoint of a phase 3 test thro...

Roche discards $120M tau prospect, sending back legal rights to UCB

.Roche has actually given back the rights to UCB's anti-tau antibody bepranemab, ignoring a $120 mil...

Editas strengthens in vivo tactic via $238M Genenvant pact

.Editas Medicines has signed a $238 million biobucks pact to blend Genevant Scientific research's li...

Combo results, Vicodin miss as well as outstanding protection

.Tip has actually reported period 3 records on its own near-approval pain medicine candidate suzetri...

Angelini markers $360M biobucks pact for ph. 1 brain ailment medication

.Italy's Angelini Pharma has actually authorized a $360 thousand biobucks contract centered on a pha...

Sage lays off one-half of R&ampD group and shocks C-suite once more

.Sage Therapeutics' most current try to reduce its own pipeline as well as workforce will certainly ...

With period 1 information, Atmosphere possesses an eye on early-stage bladder cancer

.Along with its own lead applicant in a period 3 test for an unusual eye cancer cells, Atmosphere Bi...